We’ve recently updated our valuation analysis.

Centrica Valuation

Is CNA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CNA?

Other financial metrics that can be useful for relative valuation.

CNA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.3x
Enterprise Value/EBITDA-50.3x
PEG Ration/a

Price to Sales Ratio vs Peers

How does CNA's PS Ratio compare to its peers?

The above table shows the PS ratio for CNA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average2.6x
TEP Telecom Plus
1.7x27.9%UK£2.0b
NG. National Grid
1.8x1.7%UK£36.9b
UU. United Utilities Group
3.8x4.8%UK£7.0b
SVT Severn Trent
3.3x3.5%UK£6.8b
CNA Centrica
0.3x-4.6%UK£5.6b

Price-To-Sales vs Peers: CNA is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (2.6x).


Price to Earnings Ratio vs Industry

How does CNA's PE Ratio compare vs other companies in the Global Integrated Utilities Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a-0.4%
n/an/an/a

Price-To-Sales vs Industry: CNA is good value based on its Price-To-Sales Ratio (0.3x) compared to the Global Integrated Utilities industry average (1.6x)


Price to Sales Ratio vs Fair Ratio

What is CNA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CNA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ratio0.4x

Price-To-Sales vs Fair Ratio: CNA is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).


Share Price vs Fair Value

What is the Fair Price of CNA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CNA (£0.95) is trading below our estimate of fair value (£1.2)

Significantly Below Fair Value: CNA is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CNA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUK£0.95
UK£1.22
+28.9%
24.7%UK£1.65UK£0.50n/a15
Nov ’23UK£0.78
UK£1.17
+50.5%
25.5%UK£1.60UK£0.50n/a15
Oct ’23UK£0.71
UK£1.17
+65.6%
24.2%UK£1.60UK£0.50n/a15
Sep ’23UK£0.77
UK£1.16
+51.2%
23.9%UK£1.60UK£0.50n/a15
Aug ’23UK£0.89
UK£1.08
+21.5%
24.8%UK£1.40UK£0.50n/a14
Jul ’23UK£0.81
UK£1.00
+23.4%
25.4%UK£1.40UK£0.50n/a16
Jun ’23UK£0.81
UK£0.99
+22.4%
26.1%UK£1.40UK£0.50n/a15
May ’23UK£0.79
UK£0.92
+16.1%
23.3%UK£1.30UK£0.50n/a15
Apr ’23UK£0.78
UK£0.92
+17.7%
23.3%UK£1.30UK£0.50n/a15
Mar ’23UK£0.74
UK£0.84
+13.2%
20.7%UK£1.20UK£0.50n/a14
Feb ’23UK£0.74
UK£0.81
+8.8%
20.1%UK£1.12UK£0.50n/a16
Jan ’23UK£0.71
UK£0.75
+5.2%
24.9%UK£1.12UK£0.50n/a16
Dec ’22UK£0.66
UK£0.73
+10.7%
25.8%UK£1.12UK£0.50n/a17
Nov ’22UK£0.61
UK£0.69
+13.1%
22.4%UK£1.12UK£0.50UK£0.7817
Oct ’22UK£0.58
UK£0.65
+12.3%
15.9%UK£0.86UK£0.50UK£0.7117
Sep ’22UK£0.52
UK£0.64
+22.9%
15.0%UK£0.80UK£0.50UK£0.7717
Aug ’22UK£0.45
UK£0.63
+39.1%
15.5%UK£0.80UK£0.49UK£0.8918
Jul ’22UK£0.53
UK£0.63
+19.6%
15.7%UK£0.80UK£0.46UK£0.8118
Jun ’22UK£0.55
UK£0.63
+14.4%
15.7%UK£0.80UK£0.46UK£0.8118
May ’22UK£0.57
UK£0.63
+10.7%
15.0%UK£0.77UK£0.46UK£0.7918
Apr ’22UK£0.56
UK£0.62
+10.0%
14.7%UK£0.77UK£0.46UK£0.7818
Mar ’22UK£0.54
UK£0.58
+7.8%
12.6%UK£0.70UK£0.46UK£0.7416
Feb ’22UK£0.52
UK£0.57
+9.9%
13.6%UK£0.68UK£0.40UK£0.7416
Jan ’22UK£0.47
UK£0.54
+16.3%
11.9%UK£0.65UK£0.39UK£0.7115
Dec ’21UK£0.45
UK£0.54
+19.0%
12.6%UK£0.65UK£0.39UK£0.6615
Nov ’21UK£0.37
UK£0.54
+44.6%
19.6%UK£0.80UK£0.33UK£0.6115

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies